Obesity is classified into three stages based on body mass index (BMI): Class 1 (BMI 30 to 34.9), Class 2 (BMI 35 to 39.9), and Class 3 (BMI 40 or higher). These are the most widely used categories, established by the CDC and WHO. But a newer approach stages obesity not just by weight, but by how much it has affected your health, which can paint a very different picture of your actual risk.
The Three BMI-Based Classes
The standard classification system uses BMI, a ratio of your weight to your height, to sort obesity into three tiers. A BMI of 25 to 29.9 is considered overweight but not yet obese. Once you cross 30, you enter the obesity range:
- Class 1 Obesity: BMI of 30 to 34.9
- Class 2 Obesity: BMI of 35 to 39.9
- Class 3 Obesity (Severe): BMI of 40 or higher
These cutoffs matter because mortality risk rises meaningfully at the higher end. A large meta-analysis published in JAMA found that people with Class 2 or 3 obesity had a 29% higher risk of death from all causes compared to people at a normal weight. Interestingly, Class 1 obesity on its own showed little to no increase in mortality risk in the same analysis, which highlights why lumping all obesity into one category can be misleading.
Why BMI Alone Doesn’t Tell the Full Story
BMI is a useful screening tool, but it can’t distinguish between someone who carries excess weight with no health complications and someone whose weight has already triggered diabetes or heart disease. This is where the concept of “metabolically healthy obesity” comes in. Some people with a BMI over 30 have normal blood pressure, healthy blood sugar, good cholesterol levels, and no signs of liver fat accumulation. Depending on how strictly you define metabolic health, anywhere from 7% to roughly half of people with obesity fall into this category. It’s more common in women, younger adults, and those with BMIs under 35.
That said, metabolically healthy obesity may not stay healthy forever. It appears to be more of a snapshot than a permanent state, which is part of why newer staging systems try to capture the full picture.
The Edmonton Obesity Staging System
The Edmonton Obesity Staging System (EOSS) takes a fundamentally different approach. Instead of relying on BMI alone, it classifies obesity into five stages based on how much physical, mental, and metabolic damage has occurred:
- Stage 0: No obesity-related health issues. Weight is elevated, but there are no risk factors, no symptoms, and no functional limitations.
- Stage 1: Early risk factors are present, such as borderline high blood pressure or mildly elevated blood sugar, but no established disease.
- Stage 2: Established health conditions have developed. This includes diagnoses like type 2 diabetes, sleep apnea, or moderate limitations in daily activities.
- Stage 3: Significant organ damage or chronic disease is present, with meaningful impairment in quality of life.
- Stage 4: End-stage disease with severe, potentially life-threatening complications such as heart failure.
This system can reclassify people in surprising ways. A person with a BMI of 27, technically just “overweight” by standard charts, could land at Stage 2 if they already have diabetes. Meanwhile, someone with a BMI of 38 and no health problems would be Stage 0. The EOSS helps clinicians prioritize treatment based on urgency rather than weight alone.
How Fat Tissue Changes as Obesity Progresses
At the cellular level, obesity progresses through two distinct phases. First, your existing fat cells grow larger. This process, called hypertrophy, is the body’s initial response to needing more fat storage. It’s driven primarily by diet, and it accounts for most of the increase in body fat mass during weight gain.
If fat cells reach their storage capacity, the body begins producing new fat cells. This second phase is influenced more by genetics than by diet alone, and high-fat diets accelerate it in some people more than others. Once new fat cells are created, they don’t disappear with weight loss. They shrink, but they remain, which is one reason regaining weight after losing it can happen quickly. The body’s expanded network of fat cells is ready to refill.
Where Fat Sits Matters Too
Not all fat carries the same risk. Fat stored deep in the abdomen, surrounding your organs, is more metabolically active and more dangerous than fat stored just under the skin. A simple waist measurement can estimate this: for women, a waist circumference of 35 inches or more signals elevated risk from visceral fat. For men, the threshold is 40 inches. You can have a BMI in the overweight range and still carry dangerous levels of visceral fat, or have a higher BMI with fat distributed in less harmful areas.
Adjusted Thresholds for Asian Populations
The standard BMI cutoffs were developed primarily from data on European populations and don’t apply equally to everyone. Asian populations tend to develop obesity-related health problems at lower BMIs. The Western Pacific Region of the WHO has recommended that overweight for Asian individuals begins at a BMI of 23, and obesity at 25, compared to 25 and 30 for the general population. In China, the recommended obesity cutoff is 28. The American Diabetes Association recommends diabetes screening for Asian Americans starting at a BMI of 23, recognizing that waiting until BMI 25 or 30 would miss many people already at significant risk.
How Obesity Is Staged in Children
Children and teenagers are still growing, so their obesity isn’t measured against fixed BMI numbers. Instead, a child’s BMI is compared to other children of the same age and sex using percentile charts. Obesity in children is defined as a BMI at or above the 95th percentile for their age group. Severe obesity uses an even higher threshold, typically 120% of the 95th percentile. These percentile-based categories are used until age 20, when adult BMI ranges take over.
When Treatment Intensity Increases
The stage of obesity directly influences what treatments are recommended. Lifestyle changes like diet modification and increased physical activity are considered first-line approaches across all stages. As BMI increases or health complications develop, more intensive options come into play.
Metabolic and bariatric surgery is recommended for anyone with a BMI over 35, regardless of whether they have other health conditions. For people with a BMI between 30 and 35, surgery becomes an option if they have metabolic diseases like type 2 diabetes, or if they haven’t been able to achieve lasting weight loss through other methods. For Asian patients, these surgical thresholds are lower: surgery is offered starting at a BMI of 27.5, reflecting the adjusted risk profile. For adolescents with severe obesity and related health problems, surgery can also be considered after evaluation by a specialized team.
The shift toward staging obesity by health impact rather than weight alone is changing how these decisions get made. Two people with identical BMIs may receive very different treatment recommendations based on what’s actually happening inside their bodies.